Trials / Completed
CompletedNCT00311168
Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)
Reduce Ventricular Pacing Using Ventricular Intrinsic Preference: VIP™ Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 135 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intervention/treatment | Device: VIP On Device: VIP Off |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2006-04-05
- Last updated
- 2021-08-12
- Results posted
- 2021-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00311168. Inclusion in this directory is not an endorsement.